Remarkably, POLE mutation was found in a significant proportion of mixed endometrioid-serous carcinomas arising in young women (16%); furthermore, these tumors are thought to arise as endometrioid ECs that secondarily develop a serous morphology, with or without p53 mutations [34]. Here, TP53 is linked to serous adenocarcinoma.